The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver

Blood

Volumn 117, Issue 6, 2011, Pages 2070-2072

  Lisman, Ton ^a   Platto, Marco ^b   Meijers, Joost C M ^c   Haagsma, Elizabeth B ^a   Colledan, Michele ^b   Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; GRAFT RECIPIENT; HEMOSTASIS; HUMAN; INFANT; LIVER GRAFT; LIVER TRANSPLANTATION; PEDIATRICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 79951471476     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-08-300913     Document Type: Article

References (17)

1. Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24(4):250-258. (Pubitemid 47174040)
2. Banfi G, Del Fabbro M. Biological variation in tests of hemostasis. Semin Thromb Hemost. 2009;35(1):119-126.
3. Lowe GD, Rumley A, Woodward M, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997;97(4): 775-784. (Pubitemid 27321375)
4. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80(8): 1998-2005.
5. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood. 1988;72(5):1651-1657. (Pubitemid 18268649)
6. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70(1):165-172. (Pubitemid 17111257)
7. Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev. 2010;24(2):63-68.
8. Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95(2): 362-372.
9. Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo-a closer look. Thromb Haemost. 2001;86(3):855-861. (Pubitemid 32834197)
10. Madeira CL, Layman ME, de Vera RE, Fontes PA, Ragni MV. Extrahepatic factor VIII production in transplant recipient of hemophilia donor liver. Blood. 2009;113(21):5364-5365.
11. Franchini M, Montagnana M, Manzato F, Vescovi PP. Thyroid dysfunction and hemostasis: an issue still unresolved. Semin Thromb Hemost. 2009;35(3):288-294.
12. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol. 2002;22(2):201-210. (Pubitemid 34127028)
13. Andrew M, Mitchell L, Berry LR, Schmidt B, Hatton MW. Fibrinogen has a rapid turnover in the healthy newborn lamb. Pediatr Res. 1988; 23(3):249-252. (Pubitemid 18079917)
14. Karpatkin M, Lee M, Cohen L, McKinnell J, Nardi M. Synthesis of coagulation proteins in the fetus and neonate. J Pediatr Hematol Oncol. 2000;22(3):276-280. (Pubitemid 32268317)
15. Villar A, Aronis S, Morfini M, et al. Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A. Haemophilia. 2004;10(4):352-359. (Pubitemid 39077035)
16. Collins PW, Fischer K, Morfini M, Blanchette VS, Bjorkman S. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia. Haemophilia. 2010; doi: 10.1111/j.1365-2516.2010. 02370.x.
17. Barton P, Kalil AC, Nadel S et al. Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics. 2004;113:7-17. (Pubitemid 38063108)